IN FORCE Norms Committee — Pharmaceuticals (NC-III) Advance Authorisation 2022-10-20

DGFT Committee Minutes

Document text

1

Government of India Ministry of Commerce and Industry Department of Commerce DIRECTORATE GENERAL OF FOREIGN TRADE

Minutes of the Norms Committee – 3 Meeting No. NC/3/MEET/Oct/202223/10 dated 20/10/2022 under the Chairmanship of Shri Rajiv Kumar Soni, Jt. DGFT for considering the cases/issues under Duty Exemption Scheme (Chapter-4) of Foreign Trade Policy, 2015-20 pertaining to Chemical and Allied products falling under Chapter 29 and 30.

Following members were present in the Meeting:

Sl.<br>No. Name & Designation Department
1 Shri Shaish Kumar, Technical–1 Consultant
2 Shri D.N. Mathur, Technical–2 Consultant
In attendance
1 Shri Ajay Kumar, Deputy Director DGFT

  1. The Norms Committee has taken decision only with respect to technical aspect/ wastage norms. While redeeming the application, RAs should check that the applicant has fulfilled all requirements as prescribed in policy/procedure including those in policy circulars issued from time to time or any other provisions under FTP/HBP for issuance of Advance Authorization and regularization of the case.

  2. The committee went through the Minutes of earlier Meeting No. NC/3/MEET/Sep/202223/9 dated 07/10/2022 (actually held on 14/10/2022).

2

MANUAL CASES

MANUAL CASES
Case No. A-01
MeetingNo. NC/3/MEET/Oct/202223/10
Date 20/10/2022
Firm’s Name M/s Clean Science and TechnologyPrivate Limited,Pune
HQF. No. 01/82/050/00149/AM18/DES-III
RLA F. No. 31/83/040/00012/AM18
Advance Authorization No. and Date 3110066716 dated 02.05.2017
Subject Request of M/s CLEAN SCIENCE AND TECHNOLOGY PVT.<br>LTD., Pune for enhancement in the quantity of import items of norms<br>in respect of adhoc norms fixed against Advance Authorization No.<br>3110066716 dated 02.05.2017
Decision:<br>The Committee considered the request of firm for review of norms and as per the GST data and<br>technical details for yield of 79.18% furnished by the firm, it was decided to revise norms as under:<br>Export Product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>Mono<br>Methyl<br>Ether<br>of<br>Hydroquinone - MEHQ 99%<br>PURITY<br>1 kg<br>1<br>Phenoxy methane / Anisole PURITY 99% &<br>Above.<br>1.06 kg<br>2<br>Hydrogen Peroxide(60%)PURITY 60%<br>0.80 kg<br>3<br>Acetone (Solvent) PURITY 99% AND ABOVE<br>0.14 kg<br>RA concerned maytake further necessaryaction asper above decision of NC.
Case No. A-02
MeetingNo. NC/3/MEET/Oct/202223/10
Date 20/10/2022
Firm’s Name M/s Cipla Ltd.,Mumbai
HQ F. No. 01/82/050/00972/AM17/DES-III<br>01/82/050/00285/AM18/DES-III<br>01/82/050/00610/AM18/DES-III<br>01/82/050/00127/AM19/DES-III
RLA F. No. 03/94/040/00617/AM17<br>03/94/040/01181/AM17<br>03/94/040/00295/AM18<br>03/94/040/00822/AM18
Advance Authorization No. and Date 0310808312 dated 06.10.2016<br>0310812323 dated 03.04.2017<br>0310814908 dated 31.07.2017<br>0310818765 dated 30.01.2018
Subject Request of M/s Cipla Ltd, Mumbai for fixation of adhoc norms<br>against Advance Authorization Nos. 0310808312 dated 06.10.2016,<br>0310812323 dated 03.04.2017, 0310814908 dated 31.07.2017 and<br>0310818765 dated 30.01.2018
Decision:<br>The Committee considered the request of firm for fixation of adhoc norms and it was decided to<br>call for following information / documents from the firm:<br>(i)<br>Quantity of HFA 134 A Propellant per spray may be given for all the export<br>products.<br>(ii)<br>Quantity of Ethanol per spray may be given wherever used in the export<br>products.<br>(iii)<br>Please specify any overages used for HFA 134 A Propellant and Ethanol.

Decision: The Committee considered the request of firm for fixation of adhoc norms and it was decided to call for following information / documents from the firm:

(i) Quantity of HFA 134 A Propellant per spray may be given for all the export
products.
(ii) Quantity of Ethanol per spray may be given wherever used in the export
products.
(iii) Please specify any overages used for HFA 134 A Propellant and Ethanol.

3

Case No. A-03
Meeting No. NC/3/MEET/Oct/202223/10
Date 20.10.2022
Firm’s Name M/s ShivaPharmachem Limited
HQ F. No. 01/82/050/00926/AM15/ /DES-III<br>01/82/050/00529/AM16/ /DES-III<br>01/82/050/01116/AM15/DES-III<br>01/82/050/00105/AM16/DES-III
RLA F. No. 34/24/040/00100/AM15<br>34/24/040/00131/AM15<br>34/24/040/00200/AM15<br>34/24/040/00010/AM16
Advance Authorization No. and Date 3410040395 dated 23.07.2014,<br>3410040489 dated 27.08.2014,<br>3410040669 dated 07.11.2014<br>3410041157 dated 22.04.2015
Subject Request of M/s Shiva Pharmachem Limited for enhancement in the<br>quantity of import item in respect of adhoc norms fixed by NC -3<br>against Advance Authorization Nos. 3410040395 dated 23.07.2014<br>and 3410040489 dated 27.08.2014 to enable them to club their four<br>Advance Authorizations for regularizationpurpose
Decision:<br>Policy Relaxation Committee vide its Meeting No. 08/AM23 held on 28.06.2022 (PH Case No. 05)<br>had considered the request of firm and directed Norms Committee-3 to examine and resolve the issue based on the<br>reasons given by the firm.<br>The Committee considered the request of firm and it was decided to revise adhoc norms against<br>Advance Authorization Nos. Authorization No.3410040395 dated 23.07.2014 and 3410040489 dated 27.08.2014<br>as under:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>3,5-Dimethylbenzoyl Chloride<br>(DMBC)Assay: Min 99%)<br>1 kg<br>1<br>Mesitylene<br>/<br>1,3,5-Trimethyl<br>Benzene Assay: Min 99%<br>1.868 kg<br>Rest of the earlier Minutes would remain the same.<br>Note: The above norms are only for clubbing of all the above mentioned four Advance Authorizations for<br>closure / redemption purpose.<br>RA concerned maytake further necessaryaction asper above decision of NC.

Meeting ended with thanks to Chair and participants

Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.

Analysis

No analysis has been generated for this document yet.

Citation copied